Texas Attorney General Ken Paxton (Joel Martinez/The Monitor via AP Images, File)
November 21, 2023 02:28 PM EST
Pharma
Law

Texas at­tor­ney gen­er­al sues Pfiz­er, Tris Phar­ma over man­u­fac­tur­ing is­sues sur­round­ing AD­HD med

Nicole DeFeudis

Editor

Pfiz­er and Tris Phar­ma are at the cen­ter of a new law­suit al­leg­ing they hid man­u­fac­tur­ing prob­lems re­lat­ed to an AD­HD med­ica­tion and de­fraud­ed the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bio­gen of­fers to buy out strug­gling neu­ro part­ner Sage Ther­a­peu­tics

The next gen­er­a­tion of AI biotechs is here. Can they de­liv­er on the hype?

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

‘Just the be­gin­ning’: No­bel Prizes show the AI era has ar­rived in biotech

Chas­ing the next wave of obe­si­ty drugs, Met­sera files for an IPO

Up­dat­ed: CDER Di­rec­tor Pa­trizia Cavaz­zoni to step down ahead of Trump pres­i­den­cy

A service from the Financial Times